Breast cancer patients have also been shown to have elevated levels of circulating exosomal fibronectin, developmental endothelial locus-1 (Del-1), and the 2B splice variant of survivin (survivin-2B), compared to healthy controls [123,124,125,126]. The gene discussed is EDIL3; the disease is breast carcinoma.